Vietnam Pharma Breaks Ground On $3.2 Million Drug-Production Plant
This article was originally published in PharmAsia News
Executive Summary
Vietnam's Danapha-Nanosoma pharmaceutical company began construction of a $3.2 million factory intended to produce drugs for several major diseases. The company is being aided with technology and equipment provided by a U.S.-based partner, Affordable Quality Pharmaceuticals. The plant is expected to be completed by the end of 2010, when the company plans to produce drugs to treat cancer, diabetes, heart disease and hypertension. Danapha is the parent company in the joint venture with 51 percent of the shares. (Click here for more